|
Mechanism5-HT receptor antagonists [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism5-HT receptor antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Spofa As
0 Patents (Medical) associated with Spofa As
100 Deals associated with Spofa As
100 Translational Medicine associated with Spofa As